光醫學技術市場－全球產業規模、佔有率、趨勢、機會及預測（按應用、地區和競爭格局分類，2021-2031年）

全球光醫療技術市場預計將從 2025 年的 4.5102 億美元成長到 2031 年的 6.2864 億美元，複合年成長率為 5.69%。

該領域透過跨學科應用光療技術，包括雷射、強力脈衝光和動態療法，應對各種美容和醫療挑戰。推動這一領域發展的關鍵因素包括：全球人口快速老化，老年人更容易患上慢性皮膚病；以及患者越來越傾向於選擇微創、恢復期短的治療方式。此外，皮膚病和腫瘤疾病發生率的上升也需要精準的光治療性介入，從而形成不受消費趨勢影響的根本需求。

儘管成長前景良好，但該市場仍面臨許多挑戰。高昂的資本成本，尤其是醫用雷射系統，限制了小規模醫療機構的進入。此外，關於設備安全性和潛在副作用的嚴格監管也阻礙了產品的快速商業化。根據美國皮膚外科協會 (ASDS) 2025 年的一項調查，70% 的消費者對美容手術感興趣，其中雷射除毛最受關注。這種強烈的消費意願支撐著對光醫學解決方案的強勁需求，前提是能夠有效克服經濟和監管方面的挑戰。

市場促進因素

眼科和皮膚科疾病發生率的上升是推動光醫學技術應用的主要因素。慢性疾病和皮膚惡性腫瘤的日益增多，使得精準的診斷和治療工具（例如先進的雷射系統和動態療法）的需求變得迫切。這些技術能夠標靶治療病灶，同時最大限度地減少對周圍組織的損傷，已成為現代腫瘤學和皮膚病學不可或缺的一部分。美國癌症協會於2025年1月發布的《2025年癌症事實與數據》報告強調了這種緊迫性，該報告預測，到2025年，美國將新增212,200例黑色素瘤病例，凸顯了光治療方法在複雜皮膚疾病治療中的關鍵作用。

同時，微創美容手術需求的激增正在改變市場格局。患者越來越傾向於選擇能夠有效改善膚質且無需傳統手術恢復期和風險的美容方式，這推動了非手術緊膚設備和雷射皮膚修復的普及。技術創新進一步強化了這一趨勢，並提高了各種膚質的安全性和有效性。根據國際美容整形外科學會 (ISAPS) 於 2025 年 6 月發布的《全球美容整形外科調查報告》，2024 年全球非手術美容手術量將達到 2,050 萬例，這標誌著微創方式的大規模普及。這一商業性成功也體現在行業業績上。例如，Sisram Medical 於 2025 年 3 月宣布，其 2024 會計年度總營收為 3.491 億美元，主要得益於該公司能量型醫療設備產品組合的強勁銷售。

市場挑戰

先進光療系統所需的巨額資本投入是雷射技術廣泛應用的一大障礙，直接阻礙了市場擴張。醫用級設備給醫療服務提供者帶來了沉重的經濟負擔，尤其是對於缺乏大型醫院網路雄厚財力的獨立皮膚科醫生和小規模美容診所而言。高昂的進入門檻迫使從業者維持高昂的治療價格以確保投資回報，從而有效地阻礙了這些服務的商品化。這使得這項技術在經濟上難以惠及更廣泛的受眾，將潛在市場規模限制在富裕患者群體，並抑制了其向大眾市場的滲透。

這種經濟摩擦直接阻礙了消費者興趣轉化為實質收入成長。這些設備成本的下游影響在患者對治療經濟性的態度上顯而易見：美國皮膚外科協會 (ASDS) 2025 年的一項調查發現，24% 的消費者表示，費用是他們推遲或放棄理想美容手術的主要原因。這項數據表明，高成本技術的經濟負擔正在轉嫁給患者，從而形成價格上限，顯著限制了手術數量，阻礙了全球光醫學技術市場的整體成長。

市場趨勢

將人工智慧 (AI) 應用於精準劑量測定和個人化治療，正從根本上重塑全球光醫學技術市場，以自動化、數據驅動的通訊協定取代手動參數選擇。這項技術進步使先進的雷射和光療系統能夠即時分析患者的皮膚特徵，並動態調整能量密度和脈衝寬度，從而最大限度地提高治療效果，同時最大限度地減少熱損傷。製造商正日益重視這些智慧控制功能，以使他們的旗艦平台脫穎而出，並滿足對一致臨床結果且不受操作者差異影響的需求。這種對智慧自動化的策略關注正在帶來切實可見的財務成果。根據 Sciton 公司在 2025 年 3 月發布的「28 年成長計畫」公告，該公司的人工智慧增強型 BBL HEROic 系統正推動其光療產品組合實現 7% 的年收入成長，這印證了市場正向智慧、自適應劑量測定技術轉型。

同時，智慧穿戴式和手持式家用光療設備的普及催生了一個龐大的次市場，與專業的臨床服務相輔相成。在治療組件小型化的推動下，消費者正迅速接受獲得FDA批准的LED 面膜和手持式雷射設備，從而便捷地管理痤瘡、脫髮症和光老化等皮膚問題。這一趨勢有效地規避了專業醫療保健系統高昂的准入門檻，使製造商能夠觸及尋求便捷、持續護膚的廣大消費者群體。這一消費群體的商業性規模正變得日益顯著：根據City AM 2025年2月報道，家用設備零售商CurrentBody在2024年首次實現了年收入超過1億英鎊的突破，證實了市場對個性化光療解決方案的爆炸式需求。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球光療技術市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依應用領域分類（美容/皮膚科（除毛、紋身去除、皮膚修復等）、牙科手術、腫瘤科、眼科、疼痛管理、創傷治療等）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章 北美光醫學技術市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲光醫學技術市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區光療技術市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲光療技術市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美光醫學技術市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球光療技術市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Sisram Medical Ltd
• Beurer GmbH
• Biolitec AG
• Koninklijke Philips NV
• Lumenis Inc.
• Photomedex Inc.
• LUMIBIRD Inc.
• Candela Corporation
• Thor Photomedicine Ltd
• Johnson & Johnson

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Photomedicine Technology Market is projected to expand from USD 451.02 Million in 2025 to USD 628.64 Million by 2031, exhibiting a CAGR of 5.69%. This sector involves the multidisciplinary use of light-based technologies, such as lasers, intense pulsed light, and photodynamic therapy, to address a wide range of aesthetic and medical conditions. Key factors driving this growth include a rapidly aging global demographic prone to chronic skin ailments and a growing patient preference for minimally invasive treatments that ensure shorter recovery periods. Additionally, the increasing frequency of dermatological and oncological cases requires precise, light-based therapeutic interventions, establishing a fundamental demand that exists independently of fleeting consumer trends.

Despite these favorable growth prospects, the market confronts significant obstacles, particularly the high capital costs associated with medical laser systems, which restrict access for smaller healthcare facilities. Furthermore, stringent regulations concerning device safety and potential side effects impede rapid product commercialization. According to the American Society for Dermatologic Surgery in 2025, 70% of consumers expressed interest in considering a cosmetic procedure, with laser hair removal emerging as the top area of interest. This strong consumer intent underscores the robust demand for photomedicine solutions, provided that economic and regulatory challenges are effectively navigated.

Market Driver

The escalating incidence of ophthalmic and dermatological disorders acts as a major catalyst for the adoption of photomedicine technologies. As the prevalence of chronic conditions and skin malignancies rises, there is a critical requirement for precise diagnostic and therapeutic tools, such as advanced laser systems and photodynamic therapy. These technologies enable targeted lesion treatment with minimal harm to surrounding tissues, rendering them essential in modern oncology and dermatology. Underscoring this urgency, the American Cancer Society's 'Cancer Facts & Figures 2025' report from January 2025 estimates that 212,200 cases of melanoma will be diagnosed in the U.S. in 2025, highlighting the vital role of light-based interventions in managing complex skin diseases.

Concurrently, the surging demand for minimally invasive aesthetic procedures is transforming the market landscape. Patients are increasingly prioritizing cosmetic enhancements that deliver effective results without the downtime and risks linked to traditional surgery, driving the uptake of non-surgical tightening devices and laser skin resurfacing. This trend is reinforced by technological innovations that improve safety and efficacy across various skin types. According to the International Society of Aesthetic Plastic Surgery's June 2025 'Global Survey on Aesthetic/Cosmetic Procedures', practitioners performed 20.5 million non-surgical procedures worldwide in 2024, signaling a massive shift toward these less invasive modalities. This commercial viability is reflected in industry performance; for instance, Sisram Medical announced in March 2025 that it achieved a total revenue of US$349.1 million for the fiscal year 2024, largely supported by robust sales of its energy-based device portfolio.

Market Challenge

The substantial capital expenditure required to acquire advanced photomedicine systems presents a formidable barrier to the widespread adoption of laser technology, directly hindering market expansion. Medical-grade devices impose a massive financial burden on healthcare providers, particularly independent dermatologists and smaller aesthetic clinics that lack the financial leverage of large hospital networks. This high entry cost forces practitioners to maintain elevated procedure prices to ensure a viable return on investment, which effectively prevents the commoditization of these services. Consequently, the technology remains financially inaccessible to a broader demographic, limiting the total addressable market to affluent patient segments and stalling mass-market penetration.

This economic friction creates a direct bottleneck in converting consumer interest into actual revenue growth. The downstream effect of these equipment costs is evident in patient behavior regarding treatment affordability. According to the American Society for Dermatologic Surgery in 2025, 24% of consumers cited cost as the primary reason for delaying or avoiding desired cosmetic procedures. This statistic demonstrates that the financial burden of high-cost technology is passed on to the patient, creating a price ceiling that significantly dampens procedure volume and hampers the overall trajectory of the Global Photomedicine Technology Market.

Market Trends

The integration of Artificial Intelligence for precision dosimetry and treatment personalization is fundamentally reshaping the Global Photomedicine Technology Market by replacing manual parameter selection with automated, data-driven protocols. This technological advancement allows sophisticated laser and light systems to analyze patient skin characteristics in real-time, dynamically adjusting energy fluence and pulse duration to maximize therapeutic efficacy while minimizing thermal damage. Manufacturers are increasingly prioritizing these intelligent control features to differentiate their flagship platforms and meet the demand for consistent, operator-independent clinical outcomes. This strategic focus on smart automation is yielding tangible financial results; according to Sciton's March 2025 announcement regarding its '28 Years of Growth', the company's AI-enhanced BBL HEROic system drove a 7% year-over-year revenue increase for its light-based treatment portfolio, validating the market's shift towards intelligent, self-regulating dosimetric technologies.

Simultaneously, the proliferation of smart wearable and handheld home-use phototherapy devices is creating a massive secondary market that complements professional clinical services. Driven by the miniaturization of therapeutic components, consumers are rapidly adopting FDA-cleared LED masks and handheld laser devices that offer accessible management for conditions such as acne, alopecia, and photoaging. This trend effectively circumvents the high acquisition costs associated with professional medical systems, allowing manufacturers to tap into a broader demographic seeking convenient, ongoing skin maintenance. The commercial scale of this consumer segment is becoming increasingly significant; according to City AM in February 2025, the home-use device retailer CurrentBody reported that its annual revenue surpassed £100 million for the first time in 2024, underscoring the explosive demand for personal photomedicine solutions.

Key Market Players

• Sisram Medical Ltd
• Beurer GmbH
• Biolitec AG
• Koninklijke Philips NV
• Lumenis Inc.
• Photomedex Inc.
• LUMIBIRD Inc.
• Candela Corporation
• Thor Photomedicine Ltd
• Johnson & Johnson

Report Scope

In this report, the Global Photomedicine Technology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Photomedicine Technology Market, By Application

• Aesthetics and Dermatology (Hair Removal, Tattoo Removal, Skin Resurfacing, Other)
• Dental Procedures
• Oncology
• Ophthalmology
• Pain Management
• Wound Healing
• and Other

Photomedicine Technology Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Photomedicine Technology Market.

Available Customizations:

Global Photomedicine Technology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Photomedicine Technology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Aesthetics and Dermatology (Hair Removal, Tattoo Removal, Skin Resurfacing, Other), Dental Procedures, Oncology, Ophthalmology, Pain Management, Wound Healing, and Other)
  • 5.2.2. By Region
  • 5.2.3. By Company (2025)
• 5.3. Market Map

6. North America Photomedicine Technology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Photomedicine Technology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
  • 6.3.2. Canada Photomedicine Technology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
  • 6.3.3. Mexico Photomedicine Technology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application

7. Europe Photomedicine Technology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Photomedicine Technology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
  • 7.3.2. France Photomedicine Technology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
  • 7.3.3. United Kingdom Photomedicine Technology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
  • 7.3.4. Italy Photomedicine Technology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
  • 7.3.5. Spain Photomedicine Technology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application

8. Asia Pacific Photomedicine Technology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Photomedicine Technology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
  • 8.3.2. India Photomedicine Technology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
  • 8.3.3. Japan Photomedicine Technology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
  • 8.3.4. South Korea Photomedicine Technology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
  • 8.3.5. Australia Photomedicine Technology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application

9. Middle East & Africa Photomedicine Technology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Photomedicine Technology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
  • 9.3.2. UAE Photomedicine Technology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
  • 9.3.3. South Africa Photomedicine Technology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application

10. South America Photomedicine Technology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Photomedicine Technology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
  • 10.3.2. Colombia Photomedicine Technology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
  • 10.3.3. Argentina Photomedicine Technology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Photomedicine Technology Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Sisram Medical Ltd
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Beurer GmbH
• 15.3. Biolitec AG
• 15.4. Koninklijke Philips NV
• 15.5. Lumenis Inc.
• 15.6. Photomedex Inc.
• 15.7. LUMIBIRD Inc.
• 15.8. Candela Corporation
• 15.9. Thor Photomedicine Ltd
• 15.10. Johnson & Johnson

16. Strategic Recommendations

17. About Us & Disclaimer